# PRESS RELEASE 2009

- # [FIRMAGON® has a significantly greater probability of PSA recurrence-free survival than leuprolide in prostate cancer patients](/content/firmagon-has-a-significantly-greater-probability-of-psa-recurrence-free-survival-than-leuprolide-in-prostate-cancer-patients/index.html)

Results from a phase III pivotal study sub-analyses reported in European Urology show that…

- # [Ferring donates $3 million to the Royal Textile Academy of Bhutan](/content/ferring-donates-3-million-to-the-royal-textile-academy-of-bhutan/index.html)

Frederik Paulsen, Chairman, Ferring Pharmaceuticals, announced a $3 million donation to the Royal Textile Academy of Bhutan…

- # [Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2010 Theme Announced](/content/ferring-research-infertility-and-gynaecology-grant-frigga-2010-theme-announced/index.html)

Ferring Pharmaceuticals is proud to announce the second Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) today…

- # [New Data Supports Significant Economic and Clinical Value of MENOPUR® in IVF](/content/new-data-supports-significant-economic-and-clinical-value-of-menopur-in-ivf/index.html)

New data from an economic analysis presented today at this year’s European Society of Human Reproduction and Embryology (ESHRE) congress showed that…

- # [Ferring launches New International Fertility Media Award (FIMA) 2010](/content/ferring-launches-new-international-fertility-media-award-fima-2010/index.html)

Ferring is proud to announce the launch of its first Fertility Media Award (FIMA) today during the 25th Annual Society of Human Reproduction and Embryology (ESHRE) congress…

- # [Ferring Pharmaceuticals announces new Board Member](/content/ferring-pharmaceuticals-announces-new-board-member/index.html)

Ferring Pharmaceuticals announced today that Dr. John Patterson CBE FRCP has been appointed as a new Board Member with immediate effect…

- # [Frost & Sullivan Accolade for Ferring Pharmaceuticals](/content/frost-sullivan-accolade-for-ferring-pharmaceuticals/index.html)

The 2008 Frost & Sullivan European Human Growth Hormone Competitive Strategy Leadership Award is presented to Ferring Pharmaceuticals…

- # [FIRMAGON® (degarelix) is launched in Europe for the treatment of advanced prostate cancer](/content/firmagon-degarelix-is-launched-in-europe-for-the-treatment-of-advanced-prostate-cancer/index.html)

Today marks the European launch of FIRMAGON® (degarelix), a new treatment option in hormonal therapy for prostate cancer…

- # [Ferring Pharmaceuticals creates Executive Board](/content/ferring-pharmaceuticals-creates-executive-board/index.html)

Today, Ferring Pharmaceuticals announced the creation of a new Executive Board…

- # [European Commission grants Ferring Pharmaceuticals approval of FIRMAGON® (degarelix) for treatment of prostate cancer](/content/european-commission-grants-ferring-pharmaceuticals-approval-of-firmagon-degarelix-for-treatment-of-prostate-cancer/index.html)

Ferring Pharmaceuticals announced today that it has received marketing authorisation from the European Commission, for FIRMAGON® (degarelix)…